Tier 2 — strong
Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects
Magnesium research
2019
32(3):63-71
Bibliography
- PubMed
- PMID 32162607
- Funding
- Funding is not specified in the indexed abstract or accessible funding metadata. Consult the original publication for the declaration.
- Competing interests
- A competing-interest declaration is not available in the indexed abstract or accessible disclosure metadata.
Study snapshot
| Design | Comparative single-dose pharmacokinetic study |
|---|---|
| Model | Human participants |
| Sample | 14 healthy men |
| Intervention | 400 mg elemental magnesium as citrate or oxide after magnesium saturation |
| Duration | 5-day saturation period and 24-hour post-dose assessment |
| Endpoints | Urinary magnesium excretion; Plasma magnesium |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
Biohack Blueprint Research